FR2415631A1 - Complexe d'inclusion de cyclodextrine et d'indomethacine et procede pour sa preparation - Google Patents

Complexe d'inclusion de cyclodextrine et d'indomethacine et procede pour sa preparation

Info

Publication number
FR2415631A1
FR2415631A1 FR7901796A FR7901796A FR2415631A1 FR 2415631 A1 FR2415631 A1 FR 2415631A1 FR 7901796 A FR7901796 A FR 7901796A FR 7901796 A FR7901796 A FR 7901796A FR 2415631 A1 FR2415631 A1 FR 2415631A1
Authority
FR
France
Prior art keywords
cyclodextrin
inclusion complex
indomethacin
preparation
methacin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7901796A
Other languages
English (en)
Other versions
FR2415631B1 (fr
Inventor
Jozsef Szejtli
Lajos Szente
Agoston David
Sandor Virag
Gyula Sebestyen
Attila Mandi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of FR2415631A1 publication Critical patent/FR2415631A1/fr
Application granted granted Critical
Publication of FR2415631B1 publication Critical patent/FR2415631B1/fr
Granted legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
    • C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

L'invention concerne des composés chimiques nouveaux. Il s'agit de complexe d'inclusion de cyclodextrine et d'indo-méthacine dans un rapport molaire d'environ 2:1. Ces complexes sont utiles comme médicaments.
FR7901796A 1978-01-27 1979-01-24 Complexe d'inclusion de cyclodextrine et d'indomethacine et procede pour sa preparation Granted FR2415631A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU78CI1803A HU176215B (en) 1978-01-27 1978-01-27 Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1

Publications (2)

Publication Number Publication Date
FR2415631A1 true FR2415631A1 (fr) 1979-08-24
FR2415631B1 FR2415631B1 (fr) 1981-12-24

Family

ID=10994689

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7901796A Granted FR2415631A1 (fr) 1978-01-27 1979-01-24 Complexe d'inclusion de cyclodextrine et d'indomethacine et procede pour sa preparation

Country Status (23)

Country Link
US (1) US4228160A (fr)
JP (1) JPS54117018A (fr)
AT (1) AT360554B (fr)
AU (1) AU518750B2 (fr)
BE (1) BE873725A (fr)
CA (1) CA1119115A (fr)
CH (1) CH638819A5 (fr)
CS (1) CS207742B2 (fr)
DD (1) DD141312A1 (fr)
DE (1) DE2902297A1 (fr)
DK (1) DK154977C (fr)
ES (1) ES477181A1 (fr)
FI (1) FI65441C (fr)
FR (1) FR2415631A1 (fr)
GB (1) GB2016499B (fr)
HU (1) HU176215B (fr)
IL (1) IL56309A (fr)
IT (1) IT1118282B (fr)
NL (1) NL7808792A (fr)
NO (1) NO146637C (fr)
PL (1) PL117208B1 (fr)
SE (1) SE445353B (fr)
SU (1) SU915807A3 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000913A1 (fr) * 1984-07-27 1986-02-13 Byk Gulden Lomberg Chemische Fabrik Gesellschaft M Nouveaux complexes de substances actives

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2606074A (en) * 1946-08-21 1952-08-05 Edward H Ackermann Air distributing nozzle
US4352793A (en) * 1979-04-26 1982-10-05 Sumitomo Chemical Company, Limited Pharmaceutical composition comprising bencyclane fumarate and cyclodextrin
DE2947742C2 (de) * 1979-11-27 1986-04-03 Koch, Jürgen, Dr., 2000 Hamburg Arzneimittel, enthaltend β-Cyclodextrin
HU184066B (en) * 1979-12-28 1984-06-28 Chinoin Gyogyszer Es Vegyeszet Plant growth regulating substance and process for preparing such compound
HU181733B (en) * 1980-08-07 1983-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing sorbents containing cyclodextrin on cellulose base
HU182217B (en) * 1980-10-17 1983-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing inclusive complexes of cyclodextrines and strong inorganic oxyacids
JPS5830032B2 (ja) * 1981-02-18 1983-06-27 呉羽化学工業株式会社 ビフイダス菌の増殖剤
HU183430B (en) * 1981-05-12 1984-05-28 Chinoin Gyogyszer Es Vegyeszet Process for producing cyclodextrine inclusion complexes of n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine or n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine-hydrochloride
JPS58177949A (ja) * 1982-04-12 1983-10-18 Takeda Chem Ind Ltd ランカシジン群抗生物質包接化合物
US4425336A (en) 1982-05-24 1984-01-10 Key Pharmaceuticals, Inc. 3,4-Dihydroxy-N-[3-(4-dihydroxyphenyl)-1-methyl-n-propyl]-beta-phenethylamine cyclodextrin complexes
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
HU190818B (en) * 1982-11-09 1986-11-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for producing complexes of piperonyl-butoxide-cyclodextrin
HU191101B (en) * 1983-02-14 1987-01-28 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt,Hu Process for preparing water-soluble cyclodextrin polymers substituted with ionic groups
US4502930A (en) * 1983-06-27 1985-03-05 Agency Of Industrial Science & Technology Method for manufacture of 7-substituted quadricyclene-cyclodextrin inclusion compound
JPS6025967A (ja) * 1983-07-21 1985-02-08 Eisai Co Ltd トリパミド包接化合物
US4675395A (en) * 1984-03-14 1987-06-23 Seiwa Technological Laboratories Limited Cyclodextrin inclusion compound and process for its preparation
JPS60202115A (ja) * 1984-03-27 1985-10-12 Ichiro Shibauchi エポキシ樹脂用硬化剤
YU43290B (en) * 1986-11-13 1989-06-30 Lek Tovarna Farmacevtskih Process for preparing inclusioned complex of ibuproxane with beta-cyclodextrine
IT1204725B (it) * 1987-06-17 1989-03-10 Edmond Pharma Srl Complessi di inclusione del dipiridamolo con ciclodestrine
US4885275A (en) * 1987-10-15 1989-12-05 Eli Lilly And Company Vancomycin-HCL solutions and the lyophilization thereof
US5017566A (en) * 1987-12-30 1991-05-21 University Of Florida Redox systems for brain-targeted drug delivery
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
YU45837B (sh) * 1988-01-18 1992-07-20 LEK TOVARNA FARMACEVTSKIH IN KEMIČKIH IZDELKOV d.d. Postopek za pripravo novega inkluzijskega kompleksa nikardipina oz. njegovega hidroklorida z beta-ciklodekstrinom
DE3809808A1 (de) * 1988-03-23 1989-10-05 Hexal Pharma Gmbh & Co Kg Feste, insbesondere festorale und rektale, etofenamat enthaltende arzneimittel
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
CA2013485C (fr) * 1990-03-06 1997-04-22 John Michael Gardlik Produit solide contenant de petites particules de complexes de cyclodextrine
US5384186A (en) * 1990-05-09 1995-01-24 The Proctor & Gamble Company Non-destructive carriers for cyclodextrin complexes
US5246611A (en) * 1990-05-09 1993-09-21 The Procter & Gamble Company Non-destructive carriers for cyclodextrin complexes
US5139687A (en) * 1990-05-09 1992-08-18 The Proctor & Gamble Company Non-destructive carriers for cyclodextrin complexes
JPH07583B2 (ja) * 1990-11-21 1995-01-11 北海道糖業株式会社 水溶性五環性トリテルペン包接化合物及びその製造方法並びにそれを利用した食品、飲料、口腔用組成物
US5321014A (en) * 1991-06-28 1994-06-14 The United States Of America As Represented By The Department Of Health And Human Services Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells
US20040014695A1 (en) * 1992-06-19 2004-01-22 Supergen, Inc. Pharmaceutical formulation
US5602112A (en) * 1992-06-19 1997-02-11 Supergen, Inc. Pharmaceutical formulation
US5403828A (en) * 1992-08-13 1995-04-04 American Maize-Products Company Purification of cyclodextrin complexes
WO1995032737A1 (fr) * 1994-05-27 1995-12-07 Farmarc Nederland Bv Compostion pharmaceutique
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
US5744154A (en) * 1995-09-06 1998-04-28 Laboratoire Chauvin S.A. Ready-to-use indomethacin-based eye lotion
US5824668A (en) * 1996-11-07 1998-10-20 Supergen, Inc. Formulation for administration of steroid compounds
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
US6287603B1 (en) 1999-09-16 2001-09-11 Nestec S.A. Cyclodextrin flavor delivery systems
US20020176842A1 (en) * 2001-04-09 2002-11-28 Lyn Hughes Extended release of active ingredients
KR100473716B1 (ko) * 2002-03-27 2005-03-08 주식회사 참 존 7-디하이드로콜레스테롤 및 사이클로덱스트린의 포접복합체, 이를 포함하는 화장료 조성물 및7-디하이드로콜레스테롤의 안정화방법
BRPI0611925A2 (pt) * 2005-06-13 2010-10-13 Cargill Inc complexos de inclusão de ciclodextrina e métodos de preparação dos mesmos
WO2006137958A1 (fr) * 2005-06-13 2006-12-28 Cargill Incorporated Complexes d'inclusion de cyclodextrine et méthodes de synthèse desdits complexes
US20070010485A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010486A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070010487A1 (en) * 2005-07-06 2007-01-11 Jeff Schwegman Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
US20070009532A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar
US20070010466A1 (en) * 2005-07-06 2007-01-11 Branimir Sikic Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer
BRPI0621778A2 (pt) * 2006-06-13 2011-12-20 Cargill Inc complexos de inclusão de ciclodextrina de partìcula grande e métodos de preparar os mesmos
EP2049083A2 (fr) * 2006-12-27 2009-04-22 Cargill, Incorporated Complexes d'inclusion de cyclodextrine, et leurs procédés de préparation
US20080283693A1 (en) * 2007-05-15 2008-11-20 Evans Michael J F Propulsion apparatus and system
WO2009144927A1 (fr) * 2008-05-27 2009-12-03 富士フイルム株式会社 Composition contenant un médicament
FR2989001B1 (fr) * 2012-04-06 2017-07-21 Centre Nat Rech Scient Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine
PL3411047T3 (pl) * 2016-02-04 2021-11-15 Czap Research And Development, Llc Nośniki kompleksów inkluzyjnych cyklodekstryn o kontrolowanym uwalnianiu i stratyfikowane
CN107158403B (zh) * 2017-05-18 2020-09-08 宁夏蓝博思化学技术有限公司 异甘草素-环糊精或环糊精衍生物包合物及组合物及制备方法及用途
CN107184989B (zh) * 2017-05-18 2020-09-08 宁夏蓝博思化学技术有限公司 甘草素-环糊精或环糊精衍生物包合物及组合物及制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2959580A (en) * 1956-10-17 1960-11-08 Univ Minnesota Formation of inclusion compounds
US3061444A (en) * 1960-10-07 1962-10-30 Gen Foods Corp Inclusion compounds incorporating edible juice constituents
DE1795543C3 (de) 1961-03-22 1980-06-04 Merck & Co., Inc., Rahway, N.J. (V.St.A.) Indolyl-(3)-alkancarbonsaure-niedrig alkylester
US4054736A (en) * 1970-06-10 1977-10-18 Ono Pharmaceutical Co., Ltd. Clathrate compounds of prostaglandins or their analogues with cyclodextrin

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/75 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986000913A1 (fr) * 1984-07-27 1986-02-13 Byk Gulden Lomberg Chemische Fabrik Gesellschaft M Nouveaux complexes de substances actives

Also Published As

Publication number Publication date
CS207742B2 (en) 1981-08-31
FR2415631B1 (fr) 1981-12-24
JPS54117018A (en) 1979-09-11
ATA59179A (de) 1980-06-15
DE2902297C2 (fr) 1989-02-09
AU4367179A (en) 1979-08-02
CA1119115A (fr) 1982-03-02
NL7808792A (nl) 1979-07-31
NO790261L (no) 1979-07-30
SE445353B (sv) 1986-06-16
FI790198A (fi) 1979-07-28
IL56309A (en) 1981-09-13
AT360554B (de) 1981-01-26
PL213015A1 (pl) 1979-12-17
PL117208B1 (en) 1981-07-31
DE2902297A1 (de) 1979-08-02
NO146637B (no) 1982-08-02
AU518750B2 (en) 1981-10-15
DK154977C (da) 1989-06-12
BE873725A (fr) 1979-05-16
SU915807A3 (en) 1982-03-23
ES477181A1 (es) 1979-10-16
SE7900479L (sv) 1979-07-28
DD141312A1 (de) 1980-04-23
IT1118282B (it) 1986-02-24
IT7967050A0 (it) 1979-01-11
DK35079A (da) 1979-07-28
DK154977B (da) 1989-01-16
NO146637C (no) 1982-11-10
FI65441C (fi) 1984-05-10
US4228160A (en) 1980-10-14
GB2016499B (en) 1982-07-28
HU176215B (en) 1981-01-28
FI65441B (fi) 1984-01-31
GB2016499A (en) 1979-09-26
CH638819A5 (de) 1983-10-14

Similar Documents

Publication Publication Date Title
FR2415631A1 (fr) Complexe d'inclusion de cyclodextrine et d'indomethacine et procede pour sa preparation
FR2361353A1 (fr) Derives de cyclohexane utiles comme cristaux liquides
FR2393805A1 (fr) 1-oxyde de l'acide penicillanique et de ses esters utiles comme intermediaires chimiques
FR2430940A1 (fr) Derives de cyanopyrrole, leur procede de preparation et application comme agents fongicides permettant le controle des champignons
FR2430406A1 (fr) Complexes platine-diamine, procede d'obtention, application d'un complexe pour l'obtention d'un medicament pour le traitement du cancer et medicament ainsi obtenu
FR2430934A1 (fr) Nouveaux prostanoides et procede pour leur preparation
FR2400021A1 (fr) Preparation d'acide (1r,cis);caronaldehydique
FR2365567A1 (fr) Nouvelles piperazinylpyridines utiles comme medicaments
FR2360561A1 (fr) Nouveaux dipeptides utiles comme inhibiteurs de l'elastase
FR2388832A1 (fr) Procede de fabrication d'un complexe de polyvinylpyrrolidone et d'iode
FR2364896A1 (fr) Nouveaux derives de l'aniline utiles comme agents de lutte contre les parasites
FR2361346A1 (fr) Dipeptides utiles comme medicaments
FR2358415A1 (fr) Derives peptidiques, leur preparation et leur application en tant que medicaments
FR2357514A1 (fr) Nouvelles substances odorantes a odeur de musc et procede pour leur preparation
FR2359154A1 (fr) Derives peptidiques utiles comme medicaments et procede pour leur preparation
FR2359111A1 (fr) Nouveaux derives d'acides phenoxyphenoxy-alcanecarboxyliques utiles comme herbicides
FR2402644A1 (fr) Nouveaux nitroethylcyclopentanes utiles comme intermediaires pour la synthese des prostaglandines, et leur procede de preparation
FR2433009A1 (fr) Procede pour la preparation de dicyclopentylene(2,2'-bis(4-alkyl-6-t-butylphenols))
FR2355850A1 (fr) Composes organiques de l'etain tetrasubstitues
FR2400020A1 (fr) Procede pour la preparation de furannones
FR2437405A1 (fr) Nouveaux alcoylbenzenes substitues basiques utiles comme medicaments
FR2357520A1 (fr) Procede pour preparer des chlorures d'a-chloralcanoyle
FR2415634A1 (fr) Nouvelles 3-(n-hydroxyacetyl-n-phenyl)-amino-tetrahydro-2-furanones utiles comme agents microbicides
FR2401915A1 (fr) Procede pour la preparation de pyrazolanthrones portant un substituant sur la position 3
GB1388399A (en) Dewatering of sludges

Legal Events

Date Code Title Description
ST Notification of lapse